Vactosertib

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameVactosertib
Drug Alias NameEW-7197NOV-1301TEW-7197
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsEsophageal adenocarcinomaGastroesophageal Junction NeoplasmsSolid tumours +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedpacto Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedpacto Inc
Inactive CompaniesWeill Medical College of Cornell UniversityYonsei UniversityUniversity Hospitals Cleveland Medical Center
Active IndicationsGastroesophageal Junction NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms +[5] 
Inactive IndicationsEsophageal adenocarcinomaSolid tumoursMyeloproliferative Disorders +[9] 

Other Information

ATC CodeN/A
Related LinksDrugBank